Becton Dickinson and Co
Change company Symbol lookup
Select an option...
BDX Becton Dickinson and Co
PNFP Pinnacle Financial Partners Inc
SYF Synchrony Financial
TRV Travelers Companies Inc
IBM International Business Machines Corp
T AT&T Inc
MRK Merck & Co Inc
PFE Pfizer Inc
C Citigroup Inc
GE General Electric Co
Go

Health Care : Health Care Equipment & Supplies | Large Cap Value
Company profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Closing Price
$256.44
Day's Change
-2.52 (-0.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
260.60
Day's Low
256.18
Volume
(Above Average)
Volume:
1,495,754

10-day average volume:
1,295,822
1,495,754

BDX's position in the Health Care Equipment & Supplies industry

Industry PeersBDXABTBSXEWBAX

Summary

Company ProfileBecton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic...
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established...
Go to ABT summary
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven...
Go to BSX summary
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in...
Go to EW summary
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business...
Go to BAX summary
52-Week Change

VS. INDUSTRY
-2.66%
22.45%
10.42%
19.72%
-7.51%
Market Cap

VS. INDUSTRY
$75.2B
$220.6B
$58.1B
$55.3B
$43.8B
Beta

VS. INDUSTRY
0.8
0.7
0.9
1.1
0.7
Dividend Yield

VS. INDUSTRY
1.28%
1.45%
--
--
1.13%
P/E (TTM, GAAP)

VS. INDUSTRY
49.77x
49.51x
--
68.62x
40.59x
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$18.2B
$34.6B
$9.9B
$4.4B
$11.7B
Profit Margin

VS. INDUSTRY
8.79%
12.99%
-0.83%
18.77%
9.51%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
-4.10%
7.79%
--
11.68%
24.39%
Revenue Growth (TTM)

VS. INDUSTRY
4.92%
8.48%
-7.65%
0.88%
2.74%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.